SCHEMBL8286161

SCHEMBL8286161

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2c(Oc3ccccc3)cncc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPK1 P28482 2/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN9A Q15858 1/20 0.35
NTRK1 P04629 6/20 0.35
NTRK2 Q16620 6/20 0.35
NTRK3 Q16288 4/20 0.35
PDE11A Q9HCR9 1/20 0.35
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
IGF1R P08069 3/20 0.34
FGFR1 P11362 3/20 0.34
ICAM1 P05362 1/20 0.34
SELE P16581 1/20 0.34
BLK P51451 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286163 0.87 BRAF (0.40) CYP1A2CYP2C9CYP2C19MAPK1GAA
SCHEMBL8286166 0.85 GAA (0.37) SMN1; SMN2MAPK1GAAHPGDPDE11A
SCHEMBL8287246 0.82 GAA (0.39) SMN1; SMN2MAPK1GAAHPGDPDE11A
SCHEMBL8288000 0.81 PKM (0.35) CYP1A2CYP2C9CYP2C19SMN1; SMN2MAPK1
SCHEMBL8286454 0.81 GAA (0.38) CYP1A2SMN1; SMN2MAPK1GAAHPGD
SCHEMBL8287281 0.81 GAA (0.38) SMN1; SMN2MAPK1GAAHPGDPDE11A
SCHEMBL5872272 0.81 GAA (0.38) SMN1; SMN2MAPK1GAAHPGDPDE11A
SCHEMBL8287214 0.81 GAA (0.44) SMN1; SMN2MAPK1GAAHPGDPDE11A
SCHEMBL8287251 0.79 GAA (0.36) SMN1; SMN2MAPK1GAAHPGDPDE11A
SCHEMBL8287991 0.79 GAA (0.39) SMN1; SMN2MAPK1GAAHPGDPDE11A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed